Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds are investing together in KSK Diagnostics GmbH
Development of molecular point-of-care diagnostic tests
26-Apr-2017 -
KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. A financing round has now been ...
antimicrobial resistance
companion diagnostics
diagnostic tests
+3